| （単位：十億ドル） | 2011/9 | 2012/9 | 2013/9 | 2015/9 | 2016/9 | 2017/9 | 2018/9 | 2019/9 | 2020/9 | 2021/9 | 2022/9 | 2023/9 | 2024/9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - |
| 研究開発費 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業費用 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | - | |||
| 経常（税引前）利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | - | -1 | -1 | -1 |
| 経常（税引前）利益率（％） | -Infinity | -Infinity | -Infinity | - | - | - | - | - | - | - | - | - | - |
| 法人税等合計 | 0 | 0 | 0 | - | - | - | - | - | - | - | 0 | 0 | 0 |
| 実効税率（％） | - | - | - | - | - | - | - | ||||||
| 純利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 純利益率（％） | - | - | - | - | - | - | - | - | - | - | |||
| 一株あたり利益 | - | 0 | 0 | - | - | - | - | - | - | - | -0.23 | - | -5.97 |
| 希薄化後一株あたり利益 | - | 0 | 0 | - | - | - | - | - | - | - | -0.23 | - | -5.97 |
| 一株あたり配当金 | - | - | - | - | 0.6 | - | - | - | - | - | - | - | - |